In a recent review Kanis and Passmore concluded that there was no case for supplementation of the diet with calcium for the prevention or treatment of osteoporosis. ' We consider that present evidence, taken as a whole, points to a different conclusion. We consider the matter under five main headings: experimental calcium deficiency; human calcium requirements; the relation between calcium intake, bone mass, and bone loss; the relation between calcium and hip fracture; and the role of calcium in established osteoporosis.
Experimental evidence
The evidence that dietary calcium deficiency causes osteoporosis in adult animals was reviewed by one of us many years ago,2 has seldom been challenged, and has often been confirmed3-; deficiency may also cause osteomalacia in young animals.9 Even the osteoporosis of experimental oophorectomy is itself dependent on calcium458 and sodium intake.'0 Calcium deficiency causes osteoporosis in mammals because calcium continues to be lost in the faeces and urine even when calcium intake is restricted. The resulting negative calcium balance is met by bone resorption mediated by parathyroid hormone," which maintains the all important concentration of ionised calcium in the plasma at the expense of the skeleton. The osteomalacia of vitamin D deficiency is not due to malabsorption of calcium but to loss of the calcaemic action of vitamin D on bone.'2 Thus calcium deficiency causes osteoporosis in adult animals; vitamin D deficiency causes osteomalacia.
Calcium requirements in humans YOUNG ADULTS
The calcium requirement of human adults is generally defined as the intake at which calcium intake and output are equal, which is the same as the value at which net absorbed calcium and urinary calcium are equal. This value can be determined only by measuring calcium balance on different calcium intakes. The many hundreds of careful balance studies performed in Europe and the United States in the past 50 years converge on a mean calcium requirement of about 500-600 mg/day in normal young adults.'3"' This is illustrated in figure 1 , which shows that net absorbed calcium is equal to urinary calcium excretion when they are both about 150 mg/day. The intake required to provide this net absorption is about 550 mg/day, which is therefore the mean requirement. The allowance needed to meet this requirement in 95% of normal subjects is about 800-1000 mg.'5 Even in the widely quoted work of Malm on male Norwegian prisoners, some of whom took a year or more to "adapt" to low calcium intakes, the final computed mean calcium requirement was 420 mg/day.'6 To achieve this figure many of the subjects were in prolonged negative calcium balance and must therefore have lost significant amounts of bone before the final equilibration.
Even these calculations probably underestimate the true calcium requirement since they do not allow for dermal losses, recently estimated at 60 mg daily,'7 which must add several hundred milligrams to the requirement because fractional net absorption diminishes as intake increases (fig 1) . Children, of course, need more calcium to ensure a positive calcium balance for bone growth, and even in the third decade of life a small positive calcium balance is still required.8 NORMAL POSTMENOPAUSAL WOMEN Urinary calcium excretion rises at the menopause. This can be seen in a 24 hour urine sample but is much more apparent in the calcium:creatinine ratio after an overnight fast.'9 This is illustrated in figure 2 1) . This may help to explain why oestrogen treatment seems to be more "efficient" than calcium treatment.
Calcium intake and postmenopausal bone loss
The evidence that oestrogen treatment in adequate dosage inhibits postmenopausal bone loss is, of course, conclusive. The controversial issue is the role of dietary calcium intake and the value of calcium supplementation.
The evidence of a link between calcium intake and bone state in population studies is conflicting. Garn's studies in Central America showed no relation between calcium intake and metacarpal bone mass on a national basis.4 The Matkovic study, on the other hand, found a significantly higher bone mass in a rural community with a high calcium intake than in a comparable community with a much lower calcium intake. 48 Prospective studies of the relation between calcium intake and the rate of bone loss have also produced conflicting results. In one of these, however, all the subjects were given the same calcium supplement of 500 mg,49 which would tend to obscure the effect of dietary calcium. In another, 38 of the 54 women in the "trial" were given calcitonin or oestrogen,5 which would also obscure the effect of diet. A nine month study of 522 normal women showed a weak relation between calcium intake and bone loss'9; another showed a relation between calcium intake and bone loss in the humerus but not the radius5'; and another showed faster bone loss from the spine in 19 Figure 3 shows the cumulative changes in cortical area in the three groups of the Horsman study59 and the corresponding data from the paper by Recker et Established osteoporosis The potential role of calcium deficiency is very apparent in postmenopausal women with severe osteoporosis who present with vertebral compression fractures. These patients have a higher fasting obligatory calcium loss than normal postmenopausal women, a higher urinary hydroxyproline concentration, and, commonly, a significantly reduced absorption of calcium. 2 The urinary hydroxyproline concentration is positively related to the urinary calcium concentration and inversely related to calcium absorption'2 and can be reduced into the normal postmenopausal range by administering calcium supplements or calcitriol, or both.73-76 This response to intervention suggests that the high bone resorption in these cases is the result rather than the cause of the low absorption and high excretion of calcium. There is also some evidence of an absolute or relative impairment of bone formation in some of these patients,27 which is perhaps causally related to their low adrenal androgen concentrations." This may be regarded as an additional risk factor which delays the restoration of bone destroyed in response to the calcium demand.
Calcium supplements are widely used in managing clinical osteoporosis, but we know of only one controlled trial in which they have been randomly compared with no treatment'9; the effect of calcium was positive. When calcium has been used as a placebo against which other treatments have been compared, the placebo treated controls have shown no significant loss of bone in at least three studies.80 82 
